• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

10年内进展至终末期肾病的进行性IgA肾病的危险因素:一项病例对照研究。

Risk factors of progressive IgA nephropathy which progress to end stage renal disease within ten years: a case-control study.

作者信息

Shu Danhua, Xu Feifei, Su Zhen, Zhang Ji, Chen Chaosheng, Zhang Jianna, Ding Xiaokai, Lv Yinqiu, Lin Haixia, Huang Peipei

机构信息

Department of Nephrology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.

出版信息

BMC Nephrol. 2017 Jan 7;18(1):11. doi: 10.1186/s12882-016-0429-x.

DOI:10.1186/s12882-016-0429-x
PMID:28061828
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5219698/
Abstract

BACKGROUND

There were few related studies aiming to severe IgA nephropathy (IgAN) which could progress rapidly to end stage renal disease (ESRD) within ten years. To find valuable clinical or pathological factors and promising precautions is essential.

METHODS

A single center case-control study was performed. Fifty ESRD patients with the primary cause of IgAN and a short renal survival time of less than ten years after diagnose were enrolled in the case group. One hundred IgAN patients with a renal survival time of more than ten years were enrolled in the control group. IgA Oxford classification scores, clinical data at baseline and during the follow-up were collected. Multivariate logistic regression was used to investigate factors associated with the development of ESRD.

RESULTS

There were significant differences in baseline clinical data between these two groups, as well as the constituent ratio of Oxford MEST-score. Distinct differences were observed in time-average uric acid(TA-UA), time-average hemoglobin(TA-Hb), time-average albumin(TA-Alb), time-average total cholesterol(TA-TC) and time-average urinary protein(TA-P) during the follow-up. In multivariate logistic models, IgA Oxford score M1(OR = 5.10, P = 0.018) and eGFR(OR = 0.97, P = 0.039) at biopsy, TA-UA (OR = 2.06, P = 0.026) and TA-Hb (OR = 0.53, P = 0.022) during the follow-up were identified independent factors for developing ESRD.

CONCLUSION

IgAN patients with pathological assessment of M1, low baseline eGFR, TA-Hb and high TA-UA were more likely to progress to ESRD, and should be paid more attention. Appropriate regulations of UA, Hb and urine protein after diagnose may be a promising treatment.

摘要

背景

针对严重IgA肾病(IgAN)的相关研究较少,这类疾病可在十年内迅速进展至终末期肾病(ESRD)。寻找有价值的临床或病理因素以及有前景的预防措施至关重要。

方法

进行了一项单中心病例对照研究。病例组纳入了50例原发性IgAN导致的ESRD患者,其诊断后肾脏存活时间短于10年。对照组纳入了100例肾脏存活时间超过10年的IgAN患者。收集IgA牛津分类评分、基线及随访期间的临床数据。采用多因素logistic回归分析与ESRD发生相关的因素。

结果

两组间基线临床数据以及牛津MEST评分的构成比存在显著差异。随访期间,时间平均尿酸(TA-UA)、时间平均血红蛋白(TA-Hb)、时间平均白蛋白(TA-Alb)、时间平均总胆固醇(TA-TC)和时间平均尿蛋白(TA-P)存在明显差异。在多因素logistic模型中,活检时的IgA牛津评分M1(OR = 5.10,P = 0.018)和估算肾小球滤过率(eGFR,OR = 0.97,P = 0.039),随访期间的TA-UA(OR = 2.06,P = 0.026)和TA-Hb(OR = 0.53,P = 0.022)被确定为ESRD发生的独立因素。

结论

病理评估为M1、基线eGFR低、TA-Hb低以及TA-UA高的IgAN患者更易进展为ESRD,应予以更多关注。诊断后适当调节尿酸、血红蛋白和尿蛋白可能是一种有前景的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de61/5219698/218a04fbd3a6/12882_2016_429_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de61/5219698/218a04fbd3a6/12882_2016_429_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de61/5219698/218a04fbd3a6/12882_2016_429_Fig1_HTML.jpg

相似文献

1
Risk factors of progressive IgA nephropathy which progress to end stage renal disease within ten years: a case-control study.10年内进展至终末期肾病的进行性IgA肾病的危险因素:一项病例对照研究。
BMC Nephrol. 2017 Jan 7;18(1):11. doi: 10.1186/s12882-016-0429-x.
2
A validation study of crescents in predicting ESRD in patients with IgA nephropathy.IgA 肾病患者新月体预测终末期肾病的验证研究。
J Transl Med. 2018 May 3;16(1):115. doi: 10.1186/s12967-018-1488-5.
3
Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort.儿童和青年IgA肾病进展的危险因素:来自VALIGA欧洲队列的261例病例分析
Pediatr Nephrol. 2017 Jan;32(1):139-150. doi: 10.1007/s00467-016-3469-3. Epub 2016 Aug 25.
4
Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population.IgA 肾病患者的长期肾脏生存及其相关危险因素:来自中国成人人群 1155 例队列的研究结果。
Nephrol Dial Transplant. 2012 Apr;27(4):1479-85. doi: 10.1093/ndt/gfr527. Epub 2011 Sep 29.
5
Addition of eGFR and Age Improves the Prognostic Absolute Renal Risk-Model in 1,134 Norwegian Patients with IgA Nephropathy.将估算肾小球滤过率(eGFR)和年龄纳入考量可改善针对1134例挪威IgA肾病患者的预后绝对肾风险模型。
Am J Nephrol. 2015;41(3):210-9. doi: 10.1159/000381403. Epub 2015 Apr 9.
6
Association between serum albumin level and incidence of end-stage renal disease in patients with Immunoglobulin A nephropathy: A possible role of albumin as an antioxidant agent.血清白蛋白水平与免疫球蛋白 A 肾病患者终末期肾病发病的关系:白蛋白作为抗氧化剂的可能作用。
PLoS One. 2018 May 24;13(5):e0196655. doi: 10.1371/journal.pone.0196655. eCollection 2018.
7
Clinical and prognostic significance of C1q deposition in IgAN patients-a retrospective study.IgA 肾病患者 C1q 沉积的临床和预后意义:一项回顾性研究。
Int Immunopharmacol. 2020 Nov;88:106896. doi: 10.1016/j.intimp.2020.106896. Epub 2020 Oct 14.
8
Mesangial C4d deposition may predict progression of kidney disease in pediatric patients with IgA nephropathy.系膜C4d沉积可能预测儿童IgA肾病患者的肾脏疾病进展。
Pediatr Nephrol. 2017 Jul;32(7):1211-1220. doi: 10.1007/s00467-017-3610-y. Epub 2017 Feb 23.
9
The MEST score provides earlier risk prediction in lgA nephropathy.MEST 评分可更早预测 IgA 肾病的风险。
Kidney Int. 2016 Jan;89(1):167-75. doi: 10.1038/ki.2015.322.
10
To evaluate the utility of Oxford classification in predicting renal outcome in IgA nephropathy patients.评估牛津分类在预测 IgA 肾病患者肾脏结局中的效用。
Int Urol Nephrol. 2024 Jan;56(1):345-353. doi: 10.1007/s11255-023-03685-z. Epub 2023 Jun 28.

引用本文的文献

1
Development and validation of personalized risk prediction models for patients with IgA nephropathy: a nationwide multicenter cohort study.IgA肾病患者个性化风险预测模型的开发与验证:一项全国多中心队列研究
J Nephrol. 2025 Jul 11. doi: 10.1007/s40620-025-02338-x.
2
Type 2 diabetes mellitus with chronic kidney disease benefits from long-term restriction of dietary protein intake: a 10-year retrospective cohort study.2型糖尿病合并慢性肾脏病患者可从长期限制饮食蛋白质摄入中获益:一项10年回顾性队列研究
BMC Nutr. 2025 Jul 5;11(1):131. doi: 10.1186/s40795-025-01119-w.
3
A prognostic model of immunoglobulin A nephropathy using artificial neural network: a retrospective study based on integrated Chinese and Western Medicine.

本文引用的文献

1
Markers for the progression of IgA nephropathy.IgA肾病进展的标志物。
J Nephrol. 2016 Aug;29(4):535-41. doi: 10.1007/s40620-016-0299-0. Epub 2016 May 3.
2
The MEST score provides earlier risk prediction in lgA nephropathy.MEST 评分可更早预测 IgA 肾病的风险。
Kidney Int. 2016 Jan;89(1):167-75. doi: 10.1038/ki.2015.322.
3
Identifying the ideal metric of proteinuria as a predictor of renal outcome in idiopathic glomerulonephritis.确定蛋白尿的理想指标,作为特发性肾小球肾炎肾脏预后的预测指标。
基于中西医结合的人工神经网络构建IgA肾病预后模型的回顾性研究
J Tradit Chin Med. 2025 Jun;45(3):676-684. doi: 10.19852/j.cnki.jtcm.2025.03.002.
4
Native T1-mapping as a predictor of progressive renal function decline in chronic kidney disease patients.本态 T1 mapping 作为慢性肾脏病患者肾功能进行性下降的预测指标。
BMC Nephrol. 2024 Apr 4;25(1):121. doi: 10.1186/s12882-024-03559-1.
5
Present and Future of IgA Nephropathy and Membranous Nephropathy Immune Monitoring: Insights from Molecular Studies.IgA 肾病和膜性肾病免疫监测的现状与未来:分子研究的启示。
Int J Mol Sci. 2023 Aug 23;24(17):13134. doi: 10.3390/ijms241713134.
6
Hyperuricemia is associated with the progression of IgA nephropathy in children.高尿酸血症与儿童 IgA 肾病的进展有关。
Pediatr Res. 2023 Sep;94(3):1057-1066. doi: 10.1038/s41390-023-02538-w. Epub 2023 Mar 13.
7
Hyperuricemia aggravates the progression of IgA nephropathy.高尿酸血症会加重IgA肾病的进展。
Int Urol Nephrol. 2022 Sep;54(9):2227-2237. doi: 10.1007/s11255-022-03125-4. Epub 2022 Jan 24.
8
Hyperuricemia, urate-lowering therapy, and kidney outcomes: a systematic review and meta-analysis.高尿酸血症、降尿酸治疗与肾脏结局:一项系统评价和荟萃分析。
Ther Adv Musculoskelet Dis. 2021 May 25;13:1759720X211016661. doi: 10.1177/1759720X211016661. eCollection 2021.
9
IgG deposits in the mesangium and capillary loops predict poor renal outcome in patients with IgA nephropathy: a single-center retrospective study.系膜和毛细血管袢中的 IgG 沉积可预测 IgA 肾病患者的不良肾脏结局:一项单中心回顾性研究。
Ren Fail. 2020 Nov;42(1):902-911. doi: 10.1080/0886022X.2020.1811120.
10
Integrated Datasets of Proteomic and Metabolomic Biomarkers to Predict Its Impacts on Comorbidities of Type 2 Diabetes Mellitus.用于预测对2型糖尿病合并症影响的蛋白质组学和代谢组学生物标志物综合数据集。
Diabetes Metab Syndr Obes. 2020 Jul 7;13:2409-2431. doi: 10.2147/DMSO.S244432. eCollection 2020.
Kidney Int. 2015 Dec;88(6):1392-1401. doi: 10.1038/ki.2015.241. Epub 2015 Aug 19.
4
Hyperuricemia is associated with progression of IgA nephropathy.高尿酸血症与IgA肾病的进展相关。
Int Urol Nephrol. 2015 Apr;47(4):673-8. doi: 10.1007/s11255-015-0939-7. Epub 2015 Mar 12.
5
IgA nephropathy in Czech patients--are we able reliably predict the outcome?捷克患者的IgA肾病——我们能否可靠地预测其预后?
Kidney Blood Press Res. 2014;39(6):555-62. doi: 10.1159/000368467. Epub 2014 Dec 14.
6
High uric acid level is a risk factor for progression of IgA nephropathy with chronic kidney disease stage G3a.高尿酸水平是IgA肾病伴慢性肾脏病G3a期进展的一个危险因素。
J Nephrol. 2015 Aug;28(4):451-6. doi: 10.1007/s40620-014-0154-0. Epub 2014 Oct 30.
7
IgA nephropathy.IgA肾病
N Engl J Med. 2013 Jun 20;368(25):2402-14. doi: 10.1056/NEJMra1206793.
8
A multicenter application and evaluation of the oxford classification of IgA nephropathy in adult chinese patients.一项多中心应用和评估 IgA 肾病牛津分类在成年中国患者中的应用。
Am J Kidney Dis. 2012 Nov;60(5):812-20. doi: 10.1053/j.ajkd.2012.06.011. Epub 2012 Jul 20.
9
Risk stratification of patients with IgA nephropathy.IgA 肾病患者的风险分层。
Am J Kidney Dis. 2012 Jun;59(6):865-73. doi: 10.1053/j.ajkd.2012.02.326. Epub 2012 Apr 11.
10
The Oxford classification of IgA nephropathy: a retrospective analysis.牛津 IgA 肾病分类:一项回顾性分析。
Am J Nephrol. 2011;34(5):435-44. doi: 10.1159/000332223. Epub 2011 Sep 28.